Dr Reddys Laboratories (RDY) Debt to Equity (2018 - 2025)
Historic Debt to Equity for Dr Reddys Laboratories (RDY) over the last 13 years, with Q3 2025 value amounting to $63.22.
- Dr Reddys Laboratories' Debt to Equity changed N/A to $63.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.22, marking a year-over-year change of. This contributed to the annual value of $0.14 for FY2025, which is 10492.99% up from last year.
- Per Dr Reddys Laboratories' latest filing, its Debt to Equity stood at $63.22 for Q3 2025.
- Dr Reddys Laboratories' Debt to Equity's 5-year high stood at $63.22 during Q3 2025, with a 5-year trough of $0.0 in Q2 2022.
- Moreover, its 5-year median value for Debt to Equity was $15.86 (2023), whereas its average is $24.5.
- In the last 5 years, Dr Reddys Laboratories' Debt to Equity skyrocketed by 3892123401.65% in 2023 and then crashed by 9935.9% in 2024.
- Over the past 5 years, Dr Reddys Laboratories' Debt to Equity (Quarter) stood at $35.38 in 2021, then crashed by 100.0% to $0.0 in 2022, then surged by 12106589927.17% to $15.86 in 2023, then plummeted by 99.58% to $0.07 in 2024, then soared by 94686.94% to $63.22 in 2025.
- Its Debt to Equity stands at $63.22 for Q3 2025, versus $56.07 for Q1 2025 and $0.07 for Q1 2024.